Or 'why Amylyx's pricing & commercialization strategy for ALS drug RELYVRIO pushes key life science industry tensions into the spotlight'
The Ghost of Martin Shkreli?
The Ghost of Martin Shkreli?
The Ghost of Martin Shkreli?
Or 'why Amylyx's pricing & commercialization strategy for ALS drug RELYVRIO pushes key life science industry tensions into the spotlight'